2025-11-11T07:36:26-06:00 2024-12-31 582676261 Rogers & Company PLLC 8300 Boone Boulevard Suite 600 Vienna VA 22182 990 2024-01-01 061389829 Albert B Sabin Vaccine Institute Inc ALBE 2028428610 2000 Pennsylvania Avenue NW 7000 Washington DC 20006 Amy Finan Chief Executive Officer 2028428610 2025-11-11 1 1 Jie Chen CPA P01049760 7038930300 2024 2025-03-06 01:10:19Z Amy Finan 2000 Pennsylvania Avenue NW 7000 Washington DC 20006 37750582 0 X www.sabin.org X 1994 MD To make vaccines more accessible, enable innovation and expand immunization. 14 13 76 0 0 0 676914 118433 39331759 36134625 128827 -339038 0 0 40137500 35914020 3064520 2345063 0 0 9595310 10645907 0 0 565038 29506935 26887370 42166765 39878340 -2029265 -3964320 15385516 13740804 3076842 5389842 12308674 8350962 X To make vaccines more accessible, enable innovation and expand immunization across the globe. 0 0 28454474 31583685 Vaccine Research & DevelopmentThe Sabin Vaccine Institute advances innovative vaccine research to address infectious and emerging global health threats. Sabin focuses on developing scientifically promising vaccine candidates with limited commercial potential, targeting diseases that affect the world's most vulnerable populations. Working with academic, public, and private partners, Sabin promotes open-source research. Current efforts include developing vaccines for Sudan ebolavirus and Marburg virus diseases using GSK's ChAd3 platform under a multi-year contract with the U.S. Biomedical Advanced Research and Development Authority. 7381975 2345063 4550940 Global ImmunizationThe Sabin Vaccine Institute works to increase vaccine uptake and equitable access worldwide. Through education, capacity building, and applied research, Sabin strengthens national and community systems to turn vaccines into vaccinations. Programs empower local immunization leaders, improve surveillance and data use, and advance evidence-based approaches for vaccine delivery and confidence. Sabin's Boost community connects global immunization professionals; its Vaccine Acceptance & Delivery and Applied Epidemiology teams address behavioral, social, and scientific barriers. Sabin also leads global coalitions such as the HPV Consortium and Coalition Against Typhoid to expand the use of underutilized vaccines. 35836449 1 1 0 1 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 1 1 1 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 26 0 1 76 1 0 0 0 0 0 0 0 0 0 0 0 0 X 14 13 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 MD DC NY CA FL WA X The Organization 2406059555 2000 Pennsylvania Ave NW Suite 700 Washington DC 20006 Finan Amy CEO 40.00 X X 517124 0 34268 Adegbola Richard Trustee 2.00 X 0 0 0 Baylor Norman Trustee 2.00 X 0 0 0 Djibo Yacine Trustee 2.00 X 0 0 0 Dubovsky Filip Trustee 2.00 X 0 0 0 Fox Elizabeth Trustee 2.00 X 0 0 0 Hoos Axel Trustee 2.00 X 0 0 0 Levine Orin Trustee 2.00 X 0 0 0 Libson Jeffrey Trustee, Secretary 2.00 X X 0 0 0 Omer Saad Trustee 2.00 X 0 0 0 Rabinovich Regina Trustee, Chair 2.00 X X 0 0 0 Salisbury David Trustee 2.00 X 0 0 0 Shea Jacqueline Trustee, Treasurer 2.00 X X 0 0 0 Suzich JoAnn Trustee 2.00 X 0 0 0 Tornieporth Nadia Trustee 2.00 X 0 0 0 Gupta Anuradha President 40.00 X 418131 0 40869 Warfield Kelly President 40.00 X 158575 0 1110 DeLeon Kiju CFO 40.00 X 351105 0 26120 Lopez Antonio Gonzalez VP 40.00 X 370468 0 41699 King Thomas VP 40.00 X 317288 0 45693 Vert-Wong Ekaterina VP 40.00 X 309941 0 45207 Garrett Denise VP 40.00 X 298511 0 31472 Waters Norman Sr Director 40.00 X 238945 0 8072 2980088 0 274510 35 0 1 0 Reithera SRL Via di Castel Romano 100 Rome IT 00128 Clinical Trial Material Production for M 14389595 PPD Development LP 929 North Front Street Wilmington NC 28401 Conduct of Clinical Trial and Regulatory 4381870 Texas Biomedical Research Institute 8715 W Military Dr San Antonio TX 78227 Conduct of Nonclinical Study 1847960 Battelle Memorial Institute Dept L 998 Columbus OH 43260 Nonclinical and Clinical trial sample an 597363 Integrated Biotherapeutics Inc 4 Research Court Suite 300 Rockville MD 20850 Nonclinical and Clinical trial sample an 567477 12 118433 118433 Federal & Other Contracts 900099 36134625 36134625 36134625 108871 108871 1388653 1381597 454965 7056 -454965 -447909 -447909 35914020 36134625 0 -339038 X 864427 864427 10000 10000 1470636 1470636 1547303 1176759 305889 64655 7395754 5696609 1387657 311488 242783 151293 82481 9009 868443 541182 295037 32224 591624 343885 220813 26926 91537 37676 53861 21227 21227 24154863 23862496 188802 103565 25873 25275 598 473255 281519 191325 411 94814 32014 62800 154807 154807 584073 467745 108268 8060 369727 208759 160768 200 316119 252600 63519 206358 175539 30819 Dues/subscriptions 242066 105226 128340 8500 Recruitment 80054 72618 7436 Books & publications 60015 59304 711 Filing fees 12582 887 11695 39878340 35836449 3476853 565038 1511941 263215 5004912 4120053 6443274 7482227 11310 3067 306415 450434 529016 493630 553870 35386 523902 625151 949353 696753 80539 64518 15385516 13740804 1711692 4158019 184172 1365150 1047651 3076842 5389842 X 5567087 3877974 6741587 4472988 12308674 8350962 15385516 13740804 -3964320 6608 0 X X 0 1 X 1 0 X 23177961 26883038 33467236 676914 118433 84323582 23177961 26883038 33467236 676914 118433 84323582 26560103 57763479 22343 29272 64893 98622 108871 324001 84647583 75466384 0.68240 0.64290 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 39878340 39878340 1000000 250000 0 0 1000000 1000000 1000000 1000000 4000000 6000000 108 161 269 250000 250000 250000 250000 1000000 1500000 529016 493630 35386 35386 Deferred compensation liability 625151 Lease termination liability 422500 1047651 X 36483420 6608 107827 114435 36368985 -454965 -454965 35914020 40441132 107827 454965 562792 39878340 0 39878340 Part X, Line 2: Management evaluated the Institute's tax positions and concluded that the Institute's financial statements do not include any uncertain tax positions. Part XI, Line 4b - Other Adjustments: Loss on asset disposal -454,965. Part XII, Line 2d - Other Adjustments: Loss on asset disposal 454,965. 0 East Asia and the Pacific - Australia, Brunei, Burma, Cambodia, 0 0 Grants to recipients located in region Subawardee support for Sabin Global Immunization Programs 119010 Europe (Including Iceland & Greenland) - Albania, Andorra, Austria, Belgium 0 0 Grants to recipients located in region Subawardee support for Sabin Global Immunization Programs 115344 South America - Argentina, Bolivia, Brazil, Chile, Columbia, Ecuador, 0 0 Grants to recipients located in region Subawardee support for Sabin Global Immunization Programs 342419 South Asia - Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, 0 0 Grants to recipients located in region Subawardee support for Sabin Global Immunization Programs 313932 Sub-Saharan Africa 0 0 Grants to recipients located in region Subawardee support for Sabin Global Immunization Programs 533777 South Asia 0 0 Fellowships and grants 7000 Sub-Saharan Africa 0 0 Fellowships and grants 39155 0 0 0 0 0 0 1470637 0 1470637 East Asia and the Pacific - Australia, Brunei, Burma, Cambodia, Subawardee support for Sabin Global Immunization Programs 7000 0 EFT East Asia and the Pacific - Australia, Brunei, Burma, Cambodia, Subawardee support for Sabin Global Immunization Programs 55728 0 EFT East Asia and the Pacific - Australia, Brunei, Burma, Cambodia, Subawardee support for Sabin Global Immunization Programs 56282 0 EFT Europe (Including Iceland & Greenland) - Albania, Andorra, Austria, Belgium Subawardee support for Sabin Global Immunization Programs 30103 0 EFT Europe (Including Iceland & Greenland) - Albania, Andorra, Austria, Belgium Subawardee support for Sabin Global Immunization Programs 70241 0 EFT Europe (Including Iceland & Greenland) - Albania, Andorra, Austria, Belgium Subawardee support for Sabin Global Immunization Programs 15000 0 EFT South America - Argentina, Bolivia, Brazil, Chile, Columbia, Ecuador, Subawardee support for Sabin Global Immunization Programs 342419 0 EFT South Asia - Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Subawardee support for Sabin Global Immunization Programs 17342 0 EFT South Asia - Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Subawardee support for Sabin Global Immunization Programs 157223 0 EFT South Asia - Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Subawardee support for Sabin Global Immunization Programs 30000 0 EFT South Asia - Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Subawardee support for Sabin Global Immunization Programs 7301 0 EFT South Asia - Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Subawardee support for Sabin Global Immunization Programs 20000 0 EFT South Asia - Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Subawardee support for Sabin Global Immunization Programs 11221 0 EFT South Asia - Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Subawardee support for Sabin Global Immunization Programs 51825 0 EFT South Asia - Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Subawardee support for Sabin Global Immunization Programs 10875 0 EFT South Asia - Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Subawardee support for Sabin Global Immunization Programs 8145 0 EFT Sub-Saharan Africa - Angola, Benin, Botswana, Burkina Faso, Subawardee support for Sabin Global Immunization Programs 60000 0 EFT Sub-Saharan Africa - Angola, Benin, Botswana, Burkina Faso, Subawardee support for Sabin Global Immunization Programs 6354 0 EFT Sub-Saharan Africa - Angola, Benin, Botswana, Burkina Faso, Subawardee support for Sabin Global Immunization Programs 119058 0 EFT Sub-Saharan Africa - Angola, Benin, Botswana, Burkina Faso, Subawardee support for Sabin Global Immunization Programs 23750 0 EFT Sub-Saharan Africa - Angola, Benin, Botswana, Burkina Faso, Subawardee support for Sabin Global Immunization Programs 6275 0 EFT Sub-Saharan Africa - Angola, Benin, Botswana, Burkina Faso, Subawardee support for Sabin Global Immunization Programs 56285 0 EFT Sub-Saharan Africa - Angola, Benin, Botswana, Burkina Faso, Subawardee support for Sabin Global Immunization Programs 205827 0 EFT Sub-Saharan Africa - Angola, Benin, Botswana, Burkina Faso, Subawardee support for Sabin Global Immunization Programs 56227 0 EFT 24 0 Fellowships and Grants South Asia - Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, 7 7000 EFT 0 Fellowships and Grants Sub-Saharan Africa - Angola, Benin, Botswana, Burkina Faso, 19 39155 EFT 0 0 0 0 0 0 0 Part I, Line 2: Grants are monitored in several ways. First, there is a due diligence process in awarding the grant. Second, a written and signed agreement is executed, which includes a detailed scope of work, budget and reporting requirements. Typically, payments are sent either when milestones are met or in accordance with an established payment schedule. Third, we require monthly, quarterly, and/or annual financial and technical reports from recipients prior to sending the subsequent payment. Fourth, and as needed, we conduct site visits. And finally, if deemed necessary, a third party reviews the accounting records of the recipient(s). 1 Loma Linda University Cash Concentration 11065 Campus Street Loma Linda CA 92350 951816009 501(c)(3) 64452 0 Social and Behavioral Research Grant Massachusetts General Hospital 55 Fruit Street GRJ 504 Boston MA 02114 041564655 501(c)(3) 96414 0 Surveillance for Enteric Fever in Asia Project Stanford PO Box 44253 San Francisco CA 94144 941156365 501(c)(3) 623161 0 Surveillance for Enteric Fever in Asia or Typhoid Projects University Of California Davis One Shields Ave Davis CA 95616 946036494 501(c)(3) 80400 0 Surveillance for Enteric Fever in Asia Project 4 0 Covid Fellowship 2 10000 0 Part I, Line 2: Grants are monitored in several ways. First, there is a due diligence process in awarding the grant. Second, a written and signed agreement is executed, which includes a detailed scope of work, budget and reporting requirements. Typically, payments are sent either when milestones are met or in accordance with an established payment schedule. Third, we require monthly, quarterly, and/or annual financial and technical reports from recipients prior to sending the subsequent payment. Fourth, and as needed, we conduct site visits. And finally, if deemed necessary, a third party reviews the accounting records of the recipient(s). X X X X X X 0 0 0 0 0 0 0 0 0 Finan Amy CEO 445924 0 65521 0 5679 0 11082 0 23186 0 551392 0 0 0 Gupta Anuradha President 367916 0 43200 0 7015 0 11902 0 28967 0 459000 0 0 0 Lopez Antonio Gonzalez VP 354934 0 8482 0 7052 0 13253 0 28446 0 412167 0 0 0 DeLeon Kiju CFO 314589 0 30800 0 5716 0 12404 0 13716 0 377225 0 0 0 King Thomas VP 294351 0 18000 0 4937 0 12099 0 33594 0 362981 0 0 0 Vert-Wong Ekaterina VP 287580 0 18000 0 4361 0 11469 0 33738 0 355148 0 0 0 Garrett Denise VP 273249 0 19800 0 5462 0 10197 0 21275 0 329983 0 0 0 Waters Norman Sr Director 228268 0 6493 0 4184 0 6904 0 1168 0 247017 0 0 0 Warfield Kelly President 157050 0 0 0 1525 0 700 0 410 0 159685 0 0 0 Form 990, Part VI, Section B, line 11b The Form 990 is prepared by an outside tax accounting firm based on independently audited financial statements. The Form 990 is then reviewed by the Controller and the CFO. Then the Form 990 is presented to the CEO and Finance Committee for their review and approval. Form 990, Part VI, Section B, line 12c Sabin's management, Board Chair and Governance Committee are reponsible for ensuring the conflict of interest policy is up-to-date and adhered to by the Trustees. Form 990, Part VI, Section B, line 15 Compensation of officers and/or key employees is set in consultation with input from the Board, Executive Committe or Chair as appropriate. Sabin uses a mix of data points including: independent salary surveys; comparable pay by similar organizations; compensation firms and our own internal pay scale. Form 990, Part VI, Section C, line 19 Governing documents (upon request), conflict of interest policy (upon request), and financial statement and Form 990 (Sabin's website). Form 990, Part IX, line 11g Transcription/translation service: Program service expenses 1,246. Management and general expenses 8,692. Fundraising expenses 0. Total expenses 9,938. Consultants: Program service expenses 1,975,540. Management and general expenses 124,686. Fundraising expenses 103,565. Total expenses 2,203,791. Contractor: Program service expenses 21,885,710. Management and general expenses 18,628. Fundraising expenses 0. Total expenses 21,904,338. Payroll expenses: Program service expenses 0. Management and general expenses 36,796. Fundraising expenses 0. Total expenses 36,796. Form 990, Part XII, Line 2c: The Organization has a Finance Committee that assumes responsibility for oversight of the audit. This process is consistent with prior years.